{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:54:17Z","timestamp":1789973657921,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2003,3,15]]},"DOI":"10.1086\/367859","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T16:45:29Z","timestamp":1058978729000},"page":"795-802","source":"Crossref","is-referenced-by-count":95,"title":["Human Immunodeficiency Virus Type 1\u2013Related Lipoatrophy and Lipohypertrophy Are Associated with Serum Concentrations of Leptin"],"prefix":"10.1093","volume":"36","author":[{"given":"G. Sonia","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizabeth D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Gavrila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolf W.","family":"Karchmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"rf1_513","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90258-4"},{"key":"rf2_514","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-130-8-199904200-00014","volume":"130","author":"Mantzoros C","year":"1999","journal-title":"Ann Intern Med"},{"key":"rf3_515","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/eje.0.1360461","volume":"136","author":"Sinha MK","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"rf4_516","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909163411211"},{"key":"rf5_517","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1430293"},{"key":"rf6_518","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-950"},{"key":"rf7_519","first-page":"149","volume":"43","author":"Martini G","year":"2001","journal-title":"Panminerva Med"},{"key":"rf8_520","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340503"},{"key":"rf9_521","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.6.1440"},{"key":"rf10_522","doi-asserted-by":"publisher","DOI":"10.1038\/43448"},{"key":"rf11_523","first-page":"799","author":"Flier JS","year":"2001","journal-title":"New York: Saunders"},{"key":"rf12_524","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.9.3089"},{"key":"rf13_525","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3092"},{"key":"rf14_526","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012437"},{"key":"rf15_527","unstructured":"Veny A, Bonjoch J, Romeu M. Cumulative risk for developing protease inhibitor-associated lipodystrophy (PI-AL) in HIV-infected patients [abstract I-92]. In: Programs and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998."},{"key":"rf16_528","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"rf17_529","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00003"},{"key":"rf18_530","unstructured":"Koko-Ekong S, Azubike U, Ekong E, Uwah A, Akinlade O. Fat redistribution in HIV patients on non-protease inhibitor (PI) regimens-study in 6 centres in Nigeria [abstract 684-T]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002."},{"key":"rf19_531","first-page":"383","volume":"25","author":"Vigouroux C","year":"1999","journal-title":"Diabetes Metab"},{"key":"rf20_532","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/ajhp\/56.22.2343","volume":"56","author":"Struble K","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"rf21_533","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.13.2050"},{"key":"rf22_534","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"rf23_535","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00008"},{"key":"rf24_536","first-page":"225","volume":"25","author":"Vigouroux C","year":"1999","journal-title":"Diabetes Metab"},{"key":"rf25_537","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/cs0940479","volume":"94","author":"Ballinger A","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"rf26_538","unstructured":"Behrens GMN, Widjaja A, Brabant G, etal Leptin and soluble leptin receptor levels in patients with abnormal fat redistribution and metabolic disturbances associated with HIV therapy [abstract 43]. In: Programs and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf27_539","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912030-00022"},{"key":"rf28_540","unstructured":"Kosmiski LA, Kuritzkes DR, Lichtenstein KA, etal Adipocyte-derived hormone levels and their correlates in the HIV lipodystrophy syndrome [abstract 40]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002."},{"key":"rf29_541","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00005"},{"key":"rf30_542","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","volume":"28","author":"Warnick GR","year":"1982","journal-title":"Clin Chem"},{"key":"rf31_543","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(87)90188-4"},{"key":"rf32_544","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90203-5"},{"key":"rf33_545","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00126334-200201010-00004","volume":"29","author":"Estrada V","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf34_546","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00007"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/36\/6\/795\/910429\/36-6-795.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T20:26:15Z","timestamp":1585081575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/367859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,15]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,3,15]]}},"alternative-id":["10.1086\/367859"],"URL":"https:\/\/doi.org\/10.1086\/367859","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,15]]}}}